Curateq Biologics Receives NOC From Health Canada For Its Biosimilar Dyrupeg
03:19 PM, 9th Jan 2026
Intimation of receipt of Notice of Compliance from Health Canada by Curateq Biologics Private Limited a wholly owned subsidiary of the Company for its biosimilar Dyrupeg.